Trend Report: Future of Employee Experience Employee experience, and what counts as “wellness at work”, is a burning issue as people’s relationship with work increasingly gets called into question. Backslash, the cultural intelligence division of TBWA Worldwide, has released an in-depth report that identifies some dramatically new approaches to work that lie ahead, showing employers and employees how they can co-create an experience that benefits…
Wellness Tourism Will Cross the $1 Trillion Mark in 2024 In the last year, as we emerged from the pandemic, survey after survey—whether from AMEX or Accenture—revealed that travelers were seeking wellness as never before. The GWI’s new report, Global Wellness Economy Monitor 2023, provides the first hard numbers to prove it, and the boom in the wellness tourism market is one of THE big…
Gallup Research Finds Strong Association between Religion/Spirituality and Wellbeing The global mental health crisis is relentless and yet the relationship between mental wellbeing and spirituality and religion has been largely underexplored. New Gallup research (based on poll data in 152 countries and interviews with 1.5 million people) sought to shine some new light. It revealed a strong association between the importance of religiosity/spirituality in people’s…
A 2023 study published in JAMA used data from roughly 50,000 UK adults aged 60+ who wore activity trackers to minutely record their movement (and lack thereof) throughout the day. They then used AI to interpret the results and tracked people’s medical status over the next seven years. They found a very strong correlation between long hours of sitting and dementia: Those who sat at…
Unhappiness at Work Is Rising: An Employee Wellbeing Roadmap for Wellness Companies By Thierry Malleret, economist So many new surveys indicate that unhappiness at work has never been such a problem. Macro stressors—from the cost-of-living crisis (notably in Europe) to uncertainty about working from home—are taking a toll on employee wellbeing. Some industries have happier employees than others, like non-profits, perhaps thanks to the sense…
A Phase 2 randomized clinical trial published in the prestigious JAMA found that a single dose of psilocybin (accompanied by psychotherapy) resulted in a rapid, robust and sustained reduction in depressive symptoms for people with major depressive disorder. Earlier studies have suggested that psilocybin may be a promising treatment for depression for people for whom antidepressants and therapy haven’t proven effective, but those studies focused…
